Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Zurich Baker & McKenzie partner gives briefing on regulatory change in Swiss financial world

Wednesday, March 13, 2013

Beverly Chandler, Opalesque London: Marnin Michaels, Practice Group Leader of the Baker & McKenzie Zurich Wealth Management practice, has given a presentation on various types of information exchange agreements that are currently in play globally and their impact on western currencies, particularly as reference currencies.

The briefing began with a discussion of recent developments impacting the Foreign Account Tax Compliance Act (FATCA), examining the new regulation particularly from the Swiss viewpoint. In particular, Michaels looked at the Swiss-US intergovernmental agreement (IGA). Michaels stated, "The intergovernmental agreement may not be perfect, but for the Swiss marketplace was probably the best result that could have occurred."

Michaels also commented that from a tactical perspective it is clear that the Swiss government focused on industries in which they were likely to get movement rather than areas where it is not realistic to expect significant results. "For example, the insurance, fund management and pension industries have effectively been removed from the entire FATCA discussion" he said. "This is extremely significant for very large portions of the financial services sector in Switzerland."

Michaels then discussed in detail the impact on the wealth management sector of the FATCA final regulations issued in January. Of particular concern is that the final ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its